A9. Catecholamines Flashcards

1
Q

What are cathecholamines?

A

Catecholamines are post-synaptic stimulators of sympathetic receptors. They are dihydroxyphenylethlalamine structures (don’t need to know), fairly polar, and degraded by COMT.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

List the Natural Catecholamines.

A
  1. Epinephrine
  2. Norepinephrine
  3. Dopamine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the MOA of Epinephrine?

A
  1. Epinephrine works on the β 1,2 > α 1,2 receptors.
  2. Physiological release from adrenal medulla → blood volume redistribution
  3. β2 - vasodilation in muscle, brain, heart; bronchodilation; glycogenolysis
  4. α1 - vasoconstriction in skin, GI, kidney
  5. In medical dose (higher) → BP ↑ (α effects) and HR ↑ (β1)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the route of administration of Epinephrine?

A
  1. usually IM or SC injection (orally neutralized by gastric HCl)
  2. doesn’t cross BBB
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the indications of epinephrine?

A
  1. Anaphylactic shock (antagonizes histamine effect)
  2. Asthma attack (not chronic treatment though, maybe only in severe attack)
  3. Surgical vasoconstriction: ↓ absorption of local anesthetics
  4. Cardiac arrest as intracardiac injection
  5. Glaucoma - vasoconstriction in ciliary body → ↓ humor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the MOA of Norepinephrine?

A

Norepinephrine works on the α1,2 > β1 >>> β2.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are the kinetics like for Norepinephrine?

A
  1. parenteral admin (IV)
  2. lasts 2-3 minutes (maybe given as infusion)
  3. Rapidly metabolized.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What can be some adverse effects of norepinephrine administration?

A
  1. Don’t administer in peripheral veins (if possible) due to strong vasoconstrictive effect. Effect is mostly vasoconstrictive (*strongest pressor available*) + ↑ contractility
  2. Rise in blood pressure will cause reflex bradycardia. by comparison, epinephrine will increase the heart rate (this sort of thing often asked on exams)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What are the indications of norepinephrine?

A

neurogenic, septic and cardiogenic shock

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the MOA of Dopamine?

A

Dopamine works on the D > β1 > α1.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are the indications of Dopamine?

A
  1. Low dose: 0.5-2.5 microgram/kg/min. acts on D1 receptors. Good for shock kidney - dilates renal vessels.
  2. Medium dose: 2.5-5 microgram/kg/min. acts on β1 receptors. Good for acute heart failure and chronic congestive heart failure in decompensated state. Also cardiogenic shock.
  3. High dose: 5-10 microgram/kg/min. agonist on α1 receptors. Can be used as a vasoconstrictor.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What are the complications of dopamine?

A
  1. Tolerance develops via receptor downregulation
  2. Causes tachycardia (used only when strictly necessary)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

List the Synthetic catecholamines.

A
  1. Dobutamine
  2. Isoprenaline
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the MOA of Dobutamine?

A

Dobutamine is a selective β1 agonist (slight β2 activity).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the indications of Dobutamine?

A

Similar indications to dopamine, but more commonly used

  1. AHF
  2. CHF
  3. cardiogenic shock
  4. pharmacological stress testing
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the complications of Dobutamine?

A

Same complications as DA

17
Q

What is the MOA of Isoprenaline?

A
  1. Isoprenaline (AKA isoproterenol) is a non-selective β1/2
  2. not used medically anymore,
  3. was precursor structure to current β2 agonists + β blockers